Cortical signatures of cognition and their relationship to Alzheimer's disease.
Cortical signatures of cognition and their relationship to Alzheimer's disease.
复制标题
DOI:
10.1007/s11682-012-9180-5
复制
发表时间:
2012-12
影响因子:
3.2
通讯作者:
McLaren, Donald G.
中科院分区:
文献类型:
--
作者:
Gross, Alden L.;Manly, Jennifer J.;Pa, Judy;Johnson, Julene K.;Park, Lovingly Quitania;Mitchell, Meghan B.;Melrose, Rebecca J.;Inouye, Sharon K.;McLaren, Donald G.
Recent changes in diagnostic criteria for Alzheimer’s disease (AD) state that biomarkers can enhance certainty in a diagnosis of AD. In the present study, we combined cognitive function and brain morphology, a potential imaging biomarker, to predict conversion from mild cognitive impairment to AD. We identified four biomarkers, or cortical signatures of cognition (CSC), from regressions of cortical thickness on neuropsychological factors representing memory, executive function/processing speed, language, and visuospatial function among participants in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Neuropsychological factor scores were created from a previously validated multidimensional factor structure of the neuropsychological battery in ADNI. Mean thickness of each CSC at the baseline study visit was used to evaluate risk of conversion to clinical AD among participants with mild cognitive impairment (MCI) and rate of decline on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score. Of 307 MCI participants, 119 converted to AD. For all domain-specific CSC, a one standard deviation thinner cortical thickness was associated with an approximately 50% higher hazard of conversion and an increase of approximately 0.30 points annually on the CDR-SB. In combined models with a domain-specific CSC and neuropsychological factor score, both CSC and factor scores predicted conversion to AD and increasing clinical severity. As structural magnetic resonance imaging becomes more clinically routine and time-effective than neuropsychological testing, these signatures can be used as biomarkers of conversion to AD andincreasing clinical severity.
登录
查看更多内容
影响因子:
3.7
作者:
Dickerson, Bradford C.;Bakkour, Akram;Salat, David H.;Feczko, Eric;Pacheco, Jenni;Greve, Douglas N.;Grodstein, Fran;Wright, Christopher I.;Blacker, Deborah;Rosas, H. Diana;Sperling, Reisa A.;Atri, Alireza;Growdon, John H.;Hyman, Bradley T.;Morris, John C.;Fischl, Bruce;Buckner, Randy L.
通讯作者:
Buckner, Randy L.
DOI:
10.1016/s0140-6736(20)32205-4
发表时间:
2021-04-24
期刊:
Lancet (London, England)
影响因子:
--
作者:
Scheltens P;De Strooper B;Kivipelto M;Holstege H;Chételat G;Teunissen CE;Cummings J;van der Flier WM
通讯作者:
van der Flier WM
DOI:
10.1007/978-3-642-04271-3_95
发表时间:
2009
期刊:
LECTURE NOTES IN ARTIFICIAL INTELLIGENCE
影响因子:
--
作者:
Hinrichs, Chris;Singh, Vikas;Xu, Guofan;Johnson, Sterling
通讯作者:
Johnson, Sterling
影响因子:
9.9
作者:
Dickerson, B. C.;Stoub, T. R.;deToledo-Morrell, L.
通讯作者:
deToledo-Morrell, L.
影响因子:
2.6
作者:
Ahn, Hyun-Jung;Seo, Sang Won;Na, Duk L.
通讯作者:
Na, Duk L.